Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
TNGX
TNGX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
TNGX News
Tango Therapeutics Appoints New CFO and Executives to Accelerate Growth
5d ago
Newsfilter
Revolution's Cancer Drug Shows Promising Results in Trials
6d ago
stocktwits
Tango Therapeutics Executive Exercises Stock Options
Apr 08 2026
Fool
Canaccord Genuity Initiates Coverage of Tango Therapeutics with Buy Rating
Apr 02 2026
seekingalpha
Analysis of Insider Stock Transaction at Tango Therapeutics
Mar 30 2026
Fool
Tango Therapeutics Executive Sells Shares Amid Stock Surge
Mar 30 2026
NASDAQ.COM
B. Riley Increases Target Price for TANGO THERAPEUTICS INC to $21, Up from $14
Mar 27 2026
moomoo
Biotech Investment Revives as Institutional Capital Flows Back
Mar 19 2026
Globenewswire
Wall Street Analysts Adjust MU Stock Ratings
Mar 09 2026
Benzinga
Tango Therapeutics Grants Stock Options and RSUs to New Employee
Mar 06 2026
Newsfilter
Tango Therapeutics Shares Surge 24% to New 52-Week High Following Collaboration with Erasca
Mar 05 2026
seekingalpha
Health Care Stocks Decline, NYSE Health Care Index Drops 2.3%
Mar 05 2026
Yahoo Finance
Tango Therapeutics Q4 Earnings Beat Expectations
Mar 05 2026
seekingalpha
Erasca Partners with Tango for Clinical Trial of ERAS-0015
Mar 05 2026
Newsfilter
Boxer Capital Increases Stake in Tango Therapeutics
Mar 05 2026
Fool
Boxer Capital Increases Stake in Tango Therapeutics
Mar 05 2026
NASDAQ.COM
Show More News
